{"content":"<li class=\"n-box-item date-title\" data-end=\"1538020799\" data-start=\"1537934400\" data-txt=\"Monday, December 23, 2019\">Wednesday, September 26, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3393290\" data-ts=\"1538012269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALT\" target=\"_blank\">ALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393290-altimmune-readies-equity-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altimmune readies equity offering; shares down 4% after hours</a></h4><ul><li>Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/d572967ds1a.htm\" target=\"_blank\">preliminary prospectus</a> for a public offering of 1,438,848 Common Units and the same number of Pre-Funded Units.</li><li>Each Common Unit consists of one share of common stock and one warrant to purchase one share of common.</li><li>Each Pre-Funded Unit consists of a pre-funded warrant to purchase one share of common at $0.01 per share and one warrant. The price of each will be equal to the price of a Common Unit less $0.01.</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393290\" data-linked=\"Altimmune readies equity offering; shares down 4% after hours\" data-tweet=\"$ALT - Altimmune readies equity offering; shares down 4% after hours https://seekingalpha.com/news/3393290-altimmune-readies-equity-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393290-altimmune-readies-equity-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393287\" data-ts=\"1538011603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GERN\" target=\"_blank\">GERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393287-geron-to-update-investors-tomorrow-on-imetelstat-deal-janssen-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geron to update investors tomorrow on imetelstat deal with Janssen; shares down 2% after hours</a></h4><ul><li>Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) will host a <a href=\"https://seekingalpha.com/pr/17282738-geron-provide-update-imetelstat-collaboration-janssen-september-27-2018\" target=\"_blank\">conference call </a>tomorrow, September 27, at 8:00 am ET to update investors on its imetelstat development deal with Johnson &amp; Johnson's (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) Janssen unit.</li><li>Shares have doubled since early August in anticipation of Janssen staying the course.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3385577-geron-42-percent-expectations-j-and-j-continuing-imetelstat\" target=\"_blank\">Geron up 42% on expectations of J&amp;J continuing with imetelstat</a> (Aug. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393287\" data-linked=\"Geron to update investors tomorrow on imetelstat deal with Janssen; shares down 2% after hours\" data-tweet=\"$GERN $GERN $JNJ - Geron to update investors tomorrow on imetelstat deal with Janssen; shares down 2% after hours https://seekingalpha.com/news/3393287-geron-to-update-investors-tomorrow-on-imetelstat-deal-janssen-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393287-geron-to-update-investors-tomorrow-on-imetelstat-deal-janssen-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>169&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393285\" data-ts=\"1538011022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETQ\" target=\"_blank\">PETQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393285-petiq-prices-stock-offering-39-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetIQ prices stock offering at $39; shares down 1% after hours</a></h4><ul><li>PetIQ (NASDAQ:<a href='https://seekingalpha.com/symbol/PETQ' title='PetIQ'>PETQ</a>) <a href=\"https://seekingalpha.com/pr/17282719-petiq-inc-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 5M shares of common stock at $39 per share, including 3M shares by current investors. The selling shareholders have also granted underwriters the option to purchase up to 750K additional shares.</li><li>Today's close was $40.77. Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393285\" data-linked=\"PetIQ prices stock offering at $39; shares down 1% after hours\" data-tweet=\"$PETQ - PetIQ prices stock offering at $39; shares down 1% after hours https://seekingalpha.com/news/3393285-petiq-prices-stock-offering-39-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393285-petiq-prices-stock-offering-39-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393272\" data-ts=\"1538001857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRP\" target=\"_blank\">KRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393272-kimbell-royalty-partners-launches-3m-unit-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kimbell Royalty Partners launches 3M-unit public offering</a></h4><ul>     <li>Kimbell Royalty Partners (NYSE:<a href='https://seekingalpha.com/symbol/KRP' title='Kimbell Royalty Partners LP'>KRP</a>) <font color='red'>-5.7%</font> after-hours on news it has commenced a <a href=\"https://seekingalpha.com/pr/17282526-kimbell-royalty-partners-lp-announces-public-offering-common-units\" target=\"_blank\">public offering</a> of 3M common units, with an underwriters option to purchase as much as 450K additional units.</li><li>KRP says it plans to use the proceeds to repay part of the outstanding borrowings under its revolving credit facility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393272\" data-linked=\"Kimbell Royalty Partners launches 3M-unit public offering\" data-tweet=\"$KRP - Kimbell Royalty Partners launches 3M-unit public offering https://seekingalpha.com/news/3393272-kimbell-royalty-partners-launches-3m-unit-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3393272-kimbell-royalty-partners-launches-3m-unit-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393266\" data-ts=\"1537998214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIR\" target=\"_blank\">HAIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393266-restoration-roboticsplus-7_4-william-blair-starts-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restoration Robotics +7.4% as William Blair starts at Outperform</a></h4><ul>   <li>Restoration Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a>) is <font color='green'>up 7.4%</font> after hours with William Blair initiating coverage at Outperform.</li>    <li>Market share in hair transplants is continuing to grow and the company has a \"potential game-changer\" in its ARTAS iX tech, says analyst Margaret Kaczor, who expects sales to grow by at least 20% over the next few years.  The company's also added several industry veterans and expanded its capital sales force. (h/t Bloomberg)</li>    <li>All covering analysts rate the stock a Buy.</li>    <li><a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a> is <font color='red'>down 57%</font> over the past six months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393266\" data-linked=\"Restoration Robotics +7.4% as William Blair starts at Outperform\" data-tweet=\"$HAIR $VERO - Restoration Robotics +7.4% as William Blair starts at Outperform https://seekingalpha.com/news/3393266-restoration-roboticsplus-7_4-william-blair-starts-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3393266-restoration-roboticsplus-7_4-william-blair-starts-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393263\" data-ts=\"1537997776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NK\" target=\"_blank\">NK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393263-after-hours-gainers-losers-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (09/26/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='green'>+13.8%</font>. <a href='https://seekingalpha.com/symbol/KNSA' title='Kiniksa Pharmaceuticals'>KNSA</a> <font color='green'>+6.5%</font>. <a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a> <font color='green'>+5.2%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>&nbsp;<font color='green'>+2.3%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='red'>-13.5%</font>. <a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='red'>-9.4%</font>. <a href='https://seekingalpha.com/symbol/ROYT' title='Pacific Coast Oil Trust'>ROYT</a>&nbsp;<font color='red'>-5.7%.</font>&nbsp;<a href='https://seekingalpha.com/symbol/PRED' title='Predictive Technology Group, Inc.'>OTCPK:PRED</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='red'>-2.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393263\" data-linked=\"After Hours Gainers / Losers (09/26/2018)\" data-tweet=\"$NK $NK $KNSA - After Hours Gainers / Losers (09/26/2018) https://seekingalpha.com/news/3393263-after-hours-gainers-losers-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393263-after-hours-gainers-losers-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393252\" data-ts=\"1537995618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393252-comtech-telecomminus-11-q4-revenues-miss-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech Telecom -11% as Q4 revenues miss consensus</a></h4><ul>   <li>Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) missed slightly on revenues in <a href=\"https://seekingalpha.com/news/3393248-comtech-telecommunications-beats-0_14-misses-revenue\" target=\"_blank\">Q4 earnings</a> but topped profit expectations and built a record backlog.</li>    <li>Shares have <font color='red'>slipped 11%</font> after hours.</li>    <li>Revenues grew more than 13% and net income rose 2% to $7.45M. Operating income rose to $15.99M from $14.77M.</li>    <li>Bookings rose to a record-high $214.4M; book-to-bill ratio was 1.28.</li>    <li>EBITDA came to $30.7M, up from a year-ago $29.07M.</li>    <li>Cash and equivalents came to $43.5M as of July 31. Cash flows from operations were $19.7M in Q4, reducing total indebtedness by $15M (to $171.3M).</li>    <li><a href=\"https://edge.media-server.com/m6/p/hg98rnno\" target=\"_blank\">Conference call</a> to come tomorrow at 8:30 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17282599-comtech-telecommunications-corp-announces-results-fiscal-2018-fourth-quarter-full-year\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3393252\" data-linked=\"Comtech Telecom -11% as Q4 revenues miss consensus\" data-tweet=\"$CMTL - Comtech Telecom -11% as Q4 revenues miss consensus https://seekingalpha.com/news/3393252-comtech-telecomminus-11-q4-revenues-miss-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3393252-comtech-telecomminus-11-q4-revenues-miss-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393245\" data-ts=\"1537994632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSGX\" target=\"_blank\">HSGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393245-histogenics-to-meet-fda-october-30-to-review-late-stage-neocart-data-shares-up-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Histogenics to meet with FDA October 30 to review late-stage NeoCart data; shares up 13% after hours</a></h4><ul><li>Nano cap Histogenics (NASDAQ:<a href='https://seekingalpha.com/symbol/HSGX' title='Histogenics Corporation'>HSGX</a>) is up&nbsp;<font color='green'>13%</font>&nbsp;after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17282519-histogenics-meet-fda-discuss-neocart-phase-3-clinical-trial-data-potential-regulatory-pathway\" target=\"_blank\">announcement </a>that it will meet with the FDA on October 30 to discuss Phase 3 results for NeoCart and its planned BLA filing. The company says it will update investors in early November on the meeting outcome.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387845-histogenics-45-percent-announcing-results-phase-3-trial-neocart-patients-knee-cartilage\" target=\"_blank\">Histogenics down 45% on announcing results from Phase 3 trial of NeoCart in patients with knee cartilage damage</a> (Sept. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393245\" data-linked=\"Histogenics to meet with FDA October 30 to review late-stage NeoCart data; shares up 13% after hours\" data-tweet=\"$HSGX $OCGN - Histogenics to meet with FDA October 30 to review late-stage NeoCart data; shares up 13% after hours https://seekingalpha.com/news/3393245-histogenics-to-meet-fda-october-30-to-review-late-stage-neocart-data-shares-up-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393245-histogenics-to-meet-fda-october-30-to-review-late-stage-neocart-data-shares-up-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393244\" data-ts=\"1537994259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLS\" target=\"_blank\">RGLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393244-regulus-updates-on-pipeline-investors-unmoved-shares-down-7-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulus updates on pipeline; investors unmoved, shares down 7% after hours</a></h4><ul><li>Nano cap Regulus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a>) slumps&nbsp;<font color='red'>7%</font>&nbsp;after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17282517-regulus-provides-pipeline-updates\" target=\"_blank\">pipeline update</a>. Key points:</li><li>IND for hepatitis B virus &#40;HBV&#41; program to be filed in H2 2019. A Phase 1 proof-of-concept study will be first up. The company says its lead candidate, directed to one of the hose microRNAs, has shown promising efficacy.</li><li>Glioblastoma multiforme program: lead candidate has shown significant improvements in survival as monotherapy as well as in combination with Merck's TEMODAR (temozolomide) in an animal model. Additional data will be presented at the Society for Neuro-Oncology Meeting in November.</li><li>NASH: lead candidate has shown improvements in key endpoints in animal studies. The company seeks a development partner to advance.</li><li>ADPKD program: initiated a 27-week chronic mouse toxicity study. A Phase 1 trial in healthy volunteers has been suspended due to unexpected results in an earlier mouse toxicity study. Data expected in Q1 2019.</li><li><strong>Update</strong>: Share are now up&nbsp;<font color='green'>8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393244\" data-linked=\"Regulus updates on pipeline; investors unmoved, shares down 7% after hours\" data-tweet=\"$RGLS - Regulus updates on pipeline; investors unmoved, shares down 7% after hours https://seekingalpha.com/news/3393244-regulus-updates-on-pipeline-investors-unmoved-shares-down-7-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393244-regulus-updates-on-pipeline-investors-unmoved-shares-down-7-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393232\" data-ts=\"1537993418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393232-bed-bath-beyond-slumps-12-comp-sales-fall-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond slumps 12% as comp sales fall short</a></h4><ul><li>The company reported comp sales falling 0.6% Y/Y vs. expectations for a gain of 0.4%.</li><li>Operating profit of $78.9 million was about $30M shy of estimates, and revenue of $2.94B was also light.</li><li>The <a href=\"http://bedbathandbeyond.gcs-web.com/\" target=\"_blank\">conference call</a> is at 5 ET.</li><li><a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>&nbsp;<font color='red'>-12.3%</font>&nbsp;after hours</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393226-bed-bath-and-beyond-misses-0_14-misses-revenue\" target=\"_blank\">Bed Bath &amp; Beyond misses by $0.14, misses on revenue</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393232\" data-linked=\"Bed Bath &amp; Beyond slumps 12% as comp sales fall short\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond slumps 12% as comp sales fall short https://seekingalpha.com/news/3393232-bed-bath-beyond-slumps-12-comp-sales-fall-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3393232-bed-bath-beyond-slumps-12-comp-sales-fall-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393231\" data-ts=\"1537993407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393231-bed-bath-beyondminus-13_4-profits-miss-amid-flat-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond -13.4% as profits miss amid flat sales</a></h4><ul>   <li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) has <font color='red'>slipped 13.4%</font> postmarket after missing expectations with its <a href=\"https://seekingalpha.com/news/3393226-bed-bath-and-beyond-misses-0_14-misses-revenue\" target=\"_blank\">Q2 results</a> and trimming guidance for the rest of the year.</li>    <li>Revenues were flat and increasing cost of sales and SG&amp;A expenses put a dent in operating profit, down to $78.9M from $168.8M.</li>    <li>Comparable sales were down about 0.6%.</li>    <li>Net earnings fell to $48.6M from $94.2M.</li>    <li>Cash and investments balance rose by about $532M.</li>    <li>For the full year, it's slightly reduced its net sales model, expecting comparable sales relatively flat Y/Y, and net EPS at the low end of its range (about $2.00).</li>    <li>Looking further out, it says it's on track to moderate declines in operating profit and EPS this year and next, and to reach growth in EPS by fiscal 2020.</li>    <li><a href=\"https://edge.media-server.com/m6/p/6wjc6bvc\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17282551-bed-bath-and-beyond-inc-reports-results-fiscal-2018-second-quarter\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3393231\" data-linked=\"Bed Bath &amp; Beyond -13.4% as profits miss amid flat sales\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond -13.4% as profits miss amid flat sales https://seekingalpha.com/news/3393231-bed-bath-beyondminus-13_4-profits-miss-amid-flat-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3393231-bed-bath-beyondminus-13_4-profits-miss-amid-flat-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393221\" data-ts=\"1537992846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCXI\" target=\"_blank\">CCXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393221-chemocentryx-launches-75m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChemoCentryx launches $75M stock offering</a></h4><ul><li>ChemoCentryx (NASDAQ:<a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a>) <a href=\"https://seekingalpha.com/pr/17282498-chemocentryx-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a $75M public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393221\" data-linked=\"ChemoCentryx launches $75M stock offering\" data-tweet=\"$CCXI - ChemoCentryx launches $75M stock offering https://seekingalpha.com/news/3393221-chemocentryx-launches-75m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3393221-chemocentryx-launches-75m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393219\" data-ts=\"1537992762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393219-aldeyra-launches-stock-offering-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aldeyra launches stock offering; shares down 1% after hours</a></h4><ul><li>Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <a href=\"https://seekingalpha.com/pr/17282497-aldeyra-therapeutics-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of 5.25M shares of common stock. Price and terms have yet to be announced. Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393219\" data-linked=\"Aldeyra launches stock offering; shares down 1% after hours\" data-tweet=\"$ALDX - Aldeyra launches stock offering; shares down 1% after hours https://seekingalpha.com/news/3393219-aldeyra-launches-stock-offering-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393219-aldeyra-launches-stock-offering-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393217\" data-ts=\"1537992636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERU\" target=\"_blank\">VERU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393217-veru-readies-stock-offering-shares-off-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veru readies stock offering; shares off 3% after hours</a></h4><ul><li>Thinly traded nano cap Veru (NASDAQ:<a href='https://seekingalpha.com/symbol/VERU' title='Veru Inc.'>VERU</a>) slips&nbsp;<font color='red'>3%</font>&nbsp;after hours in response to its <a href=\"https://seekingalpha.com/pr/17282495-veru-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393217\" data-linked=\"Veru readies stock offering; shares off 3% after hours\" data-tweet=\"$VERU - Veru readies stock offering; shares off 3% after hours https://seekingalpha.com/news/3393217-veru-readies-stock-offering-shares-off-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3393217-veru-readies-stock-offering-shares-off-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393210\" data-ts=\"1537991751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KOS\" target=\"_blank\">KOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393210-kosmos-energy-downgraded-raymond-james-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kosmos Energy downgraded at Raymond James on valuation</a></h4><ul>     <li>Kosmos Energy (<a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a> <font color='red'>-3.4%</font>) slides after Raymond James <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/09/12409686/raymond-james-still-bullish-on-kosmos-but-risk-reward-i\" target=\"_blank\">downgrades</a> shares to Outperform from Strong Buy with a $10 price target following the stock's recent run-up near five-year highs.</li>     <li>KOS is awaiting results from the Pontoenoe exploration well in Suriname after the company and its partners spud the prospect in August, and despite the location and its relation to discoveries in neighboring Guyana, Ray Jay analyst Pavel Molchanov says success is not guaranteed, as its first Suriname project came up dry earlier this year.</li>     <li>Molchanov says a dry result directly causes pressure on KOS shares, noting \"the risk of a dry hole is mainly a matter of short-term volatility, as had been illustrated over the past year\" following previous dry holes at Hippocampe, Lamantin, and Requin Tigre.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393210\" data-linked=\"Kosmos Energy downgraded at Raymond James on valuation\" data-tweet=\"$KOS - Kosmos Energy downgraded at Raymond James on valuation https://seekingalpha.com/news/3393210-kosmos-energy-downgraded-raymond-james-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3393210-kosmos-energy-downgraded-raymond-james-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393207\" data-ts=\"1537989975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHGG\" target=\"_blank\">CHGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393207-cheggminus-12-after-disclosing-data-breach-reaffirms-q3-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chegg -12% after disclosing data breach; reaffirms Q3 guidance</a></h4><ul>     <li>Chegg (<a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a> <font color='red'>-11.6%</font>) plunges after disclosing a <a href=\"https://www.cnbc.com/2018/09/26/ed-tech-company-chegg-plunges-after-disclosing-data-breach.html\" target=\"_blank\">data breach</a> that could affect customers' user information.</li>     <li>In an <a href=\"https://www.sec.gov/Archives/edgar/data/1364954/000136495418000187/cyrus.htm\" target=\"_blank\">SEC filing</a>, Chegg says in April an unauthorized party gained access to  a company database that hosts user data for its family of brands such as EasyBib; the data included names, emails,  shipping addresses, and passwords; no social security numbers or financial information was obtained in the  incident.</li>     <li>Chegg says it does not expect the incident to have a material impact on its FY 2018 financial results and reaffirms previous guidance for Q3.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393207\" data-linked=\"Chegg -12% after disclosing data breach; reaffirms Q3 guidance\" data-tweet=\"$CHGG - Chegg -12% after disclosing data breach; reaffirms Q3 guidance https://seekingalpha.com/news/3393207-cheggminus-12-after-disclosing-data-breach-reaffirms-q3-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3393207-cheggminus-12-after-disclosing-data-breach-reaffirms-q3-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393205\" data-ts=\"1537989756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393205-gold-volatile-still-lower-post-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold volatile, but still lower post-rate hike</a></h4><ul><li>The FOMC earlier as expected hiked the Fed Funds rate by 25 basis points. Also somewhat expected, the Committee removed \"accommodative\" from its policy statement and indicated a fourth 2018 rate hike is coming in December.</li><li>Speaking at the post-meeting press conference, Chairman Jay Powell cautions against reading anything dovish in the policy statement.</li><li>Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) initially swung higher, then lower, then higher again, and is now at about the same level it was at prior to the Fed news -&nbsp;<font color='red'>down 0.4%</font>&nbsp;at $1,200 per ounce.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='ETFS Physical Swiss Gold Trust ETF'>SGOL</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust ETF'>BAR</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Shares SPDR Gold Minishares Trust ETF'>GLDM</a>, <a href='https://seekingalpha.com/symbol/IAUF' title='iShares Gold Strategy ETF'>IAUF</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3393197-feds-powell-says-removing-accommodative-signal-change-path\" target=\"_blank\">Fed's Powell says removing `accommodative' doesn't signal change in path</a> (Sept. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393183-fed-hikes-funds-rate-25-bps-third-time-year\" target=\"_blank\">The Fed hikes funds rate by 25 bps, for the third time this year</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393205\" data-linked=\"Gold volatile, but still lower post-rate hike\" data-tweet=\"$GLD $IAU $PHYS - Gold volatile, but still lower post-rate hike https://seekingalpha.com/news/3393205-gold-volatile-still-lower-post-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3393205-gold-volatile-still-lower-post-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393204\" data-ts=\"1537989589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393204-sony-to-open-cross-play-for-fortnite-on-ps4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony to open cross-play for &#39;Fortnite&#39; on PS4</a></h4><ul>    <li>Sony (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='green'>+1.9%</font>) is ending what was the last major holdout to cross-platform play of the gaming hit <i>Fortnite,</i> <a href=\"https://techcrunch.com/2018/09/26/sony-is-finally-opening-fortnite-cross-play-on-the-ps4/?utm_source=tctwreshare&amp;sr_share=twitter\" target=\"_blank\">opening up a cross-play beta</a> for the survival sensation.</li>    <li>The company had expressed security concerns about such a policy.</li>    <li>But after a \"comprehensive\" evaluation, \"SIE has identified a path toward supporting cross-platform features for select third-party content.\"</li>    <li>That means interacting with major platforms supporting Fortnite, including Android/iOS, Nintendo Switch, Xbox One, Windows and MacOS. The move will still take some time.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393204\" data-linked=\"Sony to open cross-play for &#39;Fortnite&#39; on PS4\" data-tweet=\"$SNE - Sony to open cross-play for &#39;Fortnite&#39; on PS4 https://seekingalpha.com/news/3393204-sony-to-open-cross-play-for-fortnite-on-ps4?source=tweet\" data-url=\"https://seekingalpha.com/news/3393204-sony-to-open-cross-play-for-fortnite-on-ps4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393203\" data-ts=\"1537989276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393203-piper-jaffray-raises-call-of-duty-estimates-on-battle-royale-mode\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray raises &#39;Call of Duty&#39; estimates on battle-royale mode</a></h4><ul>   <li>Piper Jaffray is expecting a payoff from <i>Call of Duty's</i> answer to the battle-royale craze in combat videogames, set to come out in just over a couple of weeks.</li>    <li>Analyst Michael Olson has an <a href=\"https://www.barrons.com/articles/activisions-answer-to-fortnite-could-dominate-the-holiday-season-1537986617\" target=\"_blank\">$88 price target</a> for Activision Blizzard (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='green'>+1.9%</font>), after reviewing positive reaction to the \"Blackout\" mode (a response to the massive-fight mechanic of hit games <i>PlayerUnknown's Battlegrounds</i> and <i>Fortnite)</i> in the upcoming <i>Call of Duty: Black Ops 4.</i></li>    <li>&ldquo;What do you get when you take the largest annual gaming franchise on Earth and combine it with the most popular new game mode?\" Olson asks. \"We believe the answer is earnings per share upside.\"</li>    <li>He's accordingly boosting expectations for 2019 EPS to $3 from $2.86, and sees Black Ops 4 sales coming in closer to 23.5M than his previous 21.5M.</li>    <li>Olson's target implies 7.2% upside from current pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393203\" data-linked=\"Piper Jaffray raises &#39;Call of Duty&#39; estimates on battle-royale mode\" data-tweet=\"$ATVI - Piper Jaffray raises &#39;Call of Duty&#39; estimates on battle-royale mode https://seekingalpha.com/news/3393203-piper-jaffray-raises-call-of-duty-estimates-on-battle-royale-mode?source=tweet\" data-url=\"https://seekingalpha.com/news/3393203-piper-jaffray-raises-call-of-duty-estimates-on-battle-royale-mode\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393200\" data-ts=\"1537988376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393200-retail-sector-shows-little-bounce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail sector shows a little bounce</a></h4><ul><li>D.A. Davidson is out defending its thesis that the mall is not dead just yet.</li><li>\"Brands that uphold a differentiated offering and emotionally connect with consumers are better insulated against competitive threats, and thus will command better pricing power,\" writes analyst John Morris in a sweeping note to clients.</li><li>The confidence from D.A. Davidson and a strong read from Nike on consumer spending trends appears to be helping to tip sentiment favorably in the broad retail sector.</li><li>Select gainers include Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+9.6%</font>), Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='green'>+4.1%</font>), Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+4.9%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+2.6%</font>), Wolverine World Wide (<a href='https://seekingalpha.com/symbol/WWW' title='Wolverine World Wide Inc.'>WWW</a> <font color='green'>+2%</font>), Rocky Brands (<a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='green'>+1.8%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='green'>+4.5%</font>), American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+3.3%</font>), Duluth Holdings (<a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings'>DLTH</a> <font color='green'>+3.7%</font>), DSW (<a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a> <font color='green'>+3.4%</font>), Big 5 Sporting Goods (<a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='green'>+5%</font>), Hibbett Sports (<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='green'>+1.3%</font>), Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a> <font color='green'>+3.1%</font>), Burlingston Stores (<a href='https://seekingalpha.com/symbol/BURL' title='Burlington Stores, Inc'>BURL</a> <font color='green'>+3.7%</font>), PVH (<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color='green'>+2.1%</font>) and Ascena Retail Group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+7.1%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3393200\" data-linked=\"Retail sector shows a little bounce\" data-tweet=\"$GOOS $GOOS $FL - Retail sector shows a little bounce https://seekingalpha.com/news/3393200-retail-sector-shows-little-bounce?source=tweet\" data-url=\"https://seekingalpha.com/news/3393200-retail-sector-shows-little-bounce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393198\" data-ts=\"1537988150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGMH\" target=\"_blank\">AGMH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393198-technology-top-5-gainers-losers-of-2_55-pm-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (09/26/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BRKS' title='Brooks Automation, Inc.'>BRKS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color='green'>+7%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MB' title='Mindbody'>MB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/COHR' title='Coherent, Inc.'>COHR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3393198\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (09/26/2018)\" data-tweet=\"$AGMH $AGMH $MYSZ - Technology - Top 5 Gainers / Losers as of 2.55 PM (09/26/2018) https://seekingalpha.com/news/3393198-technology-top-5-gainers-losers-of-2_55-pm-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393198-technology-top-5-gainers-losers-of-2_55-pm-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393195\" data-ts=\"1537987277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393195-stocks-add-to-modest-gains-after-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks add to modest gains after rate hike</a></h4><ul><li>The FOMC as expected hiked the Fed Funds rate by 25 basis points to a range of 2-2.25%. The Committee, however, removed the \"accommodative\" language from its policy statement, meaning the PhDs at the Fed now believe the Fed Funds rate has moved to a neutral level.</li><li>Markets for now are reading that as modestly dovish (though in his just-begun press conference, Chairman Powell insists the language change doesn't signal any policy shift).</li><li>S&amp;P 500 (<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a> <font color='green'>+0.3%</font>), Dow (<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a> <font color='green'>+0.3%</font>) and Nasdaq (<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a> <font color='green'>+0.8%</font>) are close to session highs.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393183-fed-hikes-funds-rate-25-bps-third-time-year\" target=\"_blank\">The Fed hikes funds rate by 25 bps, for the third time this year</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393195\" data-linked=\"Stocks add to modest gains after rate hike\" data-tweet=\"$SPY $DIA $QQQ - Stocks add to modest gains after rate hike https://seekingalpha.com/news/3393195-stocks-add-to-modest-gains-after-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3393195-stocks-add-to-modest-gains-after-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393193\" data-ts=\"1537986238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393193-schnatter-denies-buyout-talk-on-papa-johns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schnatter denies buyout talk on Papa John&#39;s</a></h4><ul><li>A spokesperson for John Schnatter has released a statement regarding the report that the Papa John's International (<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a> <font color='green'>+9.5%</font>) founder was trying to rally private equity firms for support in a takeover attempt.</li><li>Schnatter statement:&nbsp;\"John Schnatter has not reached out to or had any discussions with any private equity firm or any other entity about buying Papa John&rsquo;s. Any such report about a potential transaction involving Mr. Schnatter is totally and completely false.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393164-papa-johns-spikes-buyout-hopes\" target=\"_blank\">Papa John's spikes on buyout hopes</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393193\" data-linked=\"Schnatter denies buyout talk on Papa John&#39;s\" data-tweet=\"$PZZA - Schnatter denies buyout talk on Papa John&#39;s https://seekingalpha.com/news/3393193-schnatter-denies-buyout-talk-on-papa-johns?source=tweet\" data-url=\"https://seekingalpha.com/news/3393193-schnatter-denies-buyout-talk-on-papa-johns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393190\" data-ts=\"1537984829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGC\" target=\"_blank\">IGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393190-energy-materials-top-5-gainers-losers-of-2-00-pm-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials  - Top 5 Gainers / Losers as of 2:00 PM (09/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/UGP' title='Ultrapar Participacoes S.A.'>UGP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PGLC' title='Pershing Gold Corporation'>PGLC</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393190\" data-linked=\"Energy/Materials  - Top 5 Gainers / Losers as of 2:00 PM (09/26/2018)\" data-tweet=\"$IGC $IGC $PED - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/26/2018) https://seekingalpha.com/news/3393190-energy-materials-top-5-gainers-losers-of-2-00-pm-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393190-energy-materials-top-5-gainers-losers-of-2-00-pm-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393184\" data-ts=\"1537983194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393184-oculus-to-launch-new-quest-wireless-headset-in-spring-for-399\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oculus to launch new Quest wireless headset in spring for $399</a></h4><ul>   <li>Project Santa Cruz from Oculus (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+2.1%</font>) has a name: New stand-alone VR headset Oculus Quest is <a href=\"https://www.cnbc.com/2018/09/26/facebook-oculus-headset-project-santa-cruz.html\" target=\"_blank\">set for a spring launch</a>.</li>    <li>The headset will cost $399 and come with more than 50 titles available at launch.</li>    <li>Hand controllers will help the wireless headset replicate the experience from Oculus' wired Rift system.</li>    <li>It's likely to occupy a middle space between the lower-end $200 Oculus Go and the high-end Oculus Rift.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393184\" data-linked=\"Oculus to launch new Quest wireless headset in spring for $399\" data-tweet=\"$FB - Oculus to launch new Quest wireless headset in spring for $399 https://seekingalpha.com/news/3393184-oculus-to-launch-new-quest-wireless-headset-in-spring-for-399?source=tweet\" data-url=\"https://seekingalpha.com/news/3393184-oculus-to-launch-new-quest-wireless-headset-in-spring-for-399\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393280\" data-ts=\"1537982356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GURE\" target=\"_blank\">GURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393280-gulf-resources-to-shut-three-bromine-factories-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulf Resources to shut three bromine factories in China</a></h4><ul>     <li>Gulf Resources (<a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a> <font color='red'>-3%</font>) is lower on news it will <a href=\"https://seekingalpha.com/pr/17281646-gulf-resources-announces-receipt-closing-notice-bromine-factories-3-4-11\" target=\"_blank\">close three bromine factories in China</a> after local authorities ruled the company fell short with environmental protections.</li>     <li>GURE says it expects to take a writeoff for the closings but does not yet provide an estimate of the amount.</li>     <li>GURE says the factories have a combined net asset value of $23.7M, adding that it may need to bear the estimated $200K-$300K cost of dismantling the facilities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393280\" data-linked=\"Gulf Resources to shut three bromine factories in China\" data-tweet=\"$GURE - Gulf Resources to shut three bromine factories in China https://seekingalpha.com/news/3393280-gulf-resources-to-shut-three-bromine-factories-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3393280-gulf-resources-to-shut-three-bromine-factories-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393179\" data-ts=\"1537981647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWGH\" target=\"_blank\">GWGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393179-financials-top-5-gainers-losers-of-1-07-pm-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:07 PM (09/26/2018)</a></h4><ul><li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings'>GWGH</a> <font color='green'>+13%</font>.<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+6%</font>.<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a> <font color='green'>+4%</font>.</li><li><b>Losers: </b><a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393179\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:07 PM (09/26/2018)\" data-tweet=\"$GWGH $GWGH $CIFS - Financials - Top 5 Gainers / Losers as of 1:07 PM (09/26/2018) https://seekingalpha.com/news/3393179-financials-top-5-gainers-losers-of-1-07-pm-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393179-financials-top-5-gainers-losers-of-1-07-pm-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393175\" data-ts=\"1537980291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRUP\" target=\"_blank\">TRUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393175-report-on-trupanion-probe-is-walked-back-shares-remain-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report on Trupanion probe is walked back; shares remain down 5%</a></h4><ul><li>The Capitol Forum is now reporting that Trupanion (NYSE:<a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a>) is not being investigated by the NY Department of Financial Services. Shares are off the lows, but still&nbsp;<font color='red'>down 5.6%</font>&nbsp;on the session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393131-trupanion-5-percent-report-probe\" target=\"_blank\">Trupanion down more than 5% on report of probe</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393175\" data-linked=\"Report on Trupanion probe is walked back; shares remain down 5%\" data-tweet=\"$TRUP - Report on Trupanion probe is walked back; shares remain down 5% https://seekingalpha.com/news/3393175-report-on-trupanion-probe-is-walked-back-shares-remain-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3393175-report-on-trupanion-probe-is-walked-back-shares-remain-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393172\" data-ts=\"1537980049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393172-midday-gainers-losers-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (09/26/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+60%</font>. <a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/XOMA' title='XOMA Corporation'>XOMA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings'>GWGH</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/LQDA' title='Liquidia Technologies'>LQDA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MMYT' title='MakeMyTrip Limited'>MMYT</a> <font color='green'>+12%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/LEVB' title='Level Brands, Inc.'>LEVB</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DAC' title='Danaos Corporation'>DAC</a> <font color='red'>-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3393172\" data-linked=\"Midday Gainers / Losers (09/26/2018)\" data-tweet=\"$ALDX $ALDX $VLRX - Midday Gainers / Losers (09/26/2018) https://seekingalpha.com/news/3393172-midday-gainers-losers-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393172-midday-gainers-losers-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393164\" data-ts=\"1537978783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393164-papa-johns-spikes-on-buyout-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s spikes on buyout hopes</a></h4><ul><li>Papa John's International (<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a> <font color='green'>+6%</font>) shoots higher on reports that founder John Schnatter is looking for support from private equity firms on putting together a buyout offer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393164\" data-linked=\"Papa John&#39;s spikes on buyout hopes\" data-tweet=\"$PZZA - Papa John&#39;s spikes on buyout hopes https://seekingalpha.com/news/3393164-papa-johns-spikes-on-buyout-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3393164-papa-johns-spikes-on-buyout-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393161\" data-ts=\"1537978492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393161-delcath-completes-round-trip-down-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath completes round trip, down 22%</a></h4><ul><li>Thinly traded nano cap Delcath Systems (<a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='red'>-21.8%</font>) slumps on a 4x spike on volume, completing a round trip from its three-fold jump that began in mid-September.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3391236-delcath-57-percent-end-subscription-rights-period-approaches\" target=\"_blank\">Delcath up 57% as end of subscription rights period approaches</a> (Sept. 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389054-delcath-systems-21-percent-following-2_5m-capital-raise\" target=\"_blank\">Delcath Systems up 21% following $2.5M capital raise</a> (Sept. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393161\" data-linked=\"Delcath completes round trip, down 22%\" data-tweet=\"$DCTH - Delcath completes round trip, down 22% https://seekingalpha.com/news/3393161-delcath-completes-round-trip-down-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3393161-delcath-completes-round-trip-down-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393159\" data-ts=\"1537978262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WU\" target=\"_blank\">WU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393159-western-union-mulls-sale-of-business-payments-unit-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Union mulls sale of business-payments unit - Bloomberg</a></h4><ul><li>Western Union (NYSE:<a href='https://seekingalpha.com/symbol/WU' title='The Western Union Company'>WU</a>) has hired a financial adviser to assist with the sale of its business-payments arm, <a href=\"https://www.bloomberg.com/news/articles/2018-09-26/western-union-is-said-to-weigh-sale-of-business-payments-unit?cmpid%3D=socialflow-twitter-deals&amp;utm_medium=social&amp;utm_source=twitter&amp;utm_content=deals&amp;utm_campaign=socialflow-organic\" target=\"_blank\">reports Bloomberg</a>. The operation reportedly could be worth at least $500M.</li><li>The company in Q4 booked an impairment charge of nearly $500M following tax reform which forced sharply lower sales projections.</li><li>Shares are&nbsp;<font color='green'>up 3.1%</font>&nbsp;on the news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393159\" data-linked=\"Western Union mulls sale of business-payments unit - Bloomberg\" data-tweet=\"$WU - Western Union mulls sale of business-payments unit - Bloomberg https://seekingalpha.com/news/3393159-western-union-mulls-sale-of-business-payments-unit-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3393159-western-union-mulls-sale-of-business-payments-unit-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393156\" data-ts=\"1537978051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393156-teva-continues-selloff-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva continues selloff, down 5%</a></h4><ul><li>Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-4.8%</font>) is down on modestly higher volume. Shares have corrected ~<font color='red'>12%</font>&nbsp;since last week.</li><li>A contributing factor appears to be <a href=\"https://seekingalpha.com/pr/17281564-tg-therapeutics-inc-announces-final-phase-2-multiple-sclerosis-data-accepted-oral\" target=\"_blank\">mid-stage data</a> on TG Therapeutics' (<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='red'>-2.9%</font>) ublituximab in relapsing forms of multiple sclerosis &#40;MS&#41;. The results, to be presented at ECTRIMS in Berlin next month, showed an annualized relapse rate of 0.07, significantly below the 0.331 rate for the 40 mg dose of Copaxone (glatiramer acetate injection) in Study 5 (<a href=\"https://www.copaxone.com/Resources/pdfs/PrescribingInformation.pdf\" target=\"_blank\">package insert</a>, page 17).</li><li>In addition, all T1 Gd-enhancing brain lesions were were eliminated at week 24 and maintained at week 48. In Study 4, the median cumulative number of T1 Gd-enhancing lesions after nine months of treatment with 20 mg of Copaxone was 11 (page 16).</li></ul><div class=\"tiny-share-widget\" data-id=\"3393156\" data-linked=\"Teva continues selloff, down 5%\" data-tweet=\"$TEVA $TEVA $TGTX - Teva continues selloff, down 5% https://seekingalpha.com/news/3393156-teva-continues-selloff-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3393156-teva-continues-selloff-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393154\" data-ts=\"1537977694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393154-consumer-top-gainers-losers-of-12-00-pm-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (09/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global'>FORK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393154\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (09/26/2018)\" data-tweet=\"$YGYI $YGYI $GOOS - Consumer - Top Gainers / Losers as of 12:00 PM (09/26/2018) https://seekingalpha.com/news/3393154-consumer-top-gainers-losers-of-12-00-pm-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393154-consumer-top-gainers-losers-of-12-00-pm-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393155\" data-ts=\"1537977687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393155-aldeyraplus-43-canaccord-sees-another-150-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aldeyra +43%; Canaccord sees another 150% upside</a></h4><ul><li>Calling this morning's data a \"major positive,\" <a href=\"https://twitter.com/thenotablecalls/status/1044972334275350529\" target=\"_blank\">Canaccord slaps a</a> Street-high price target of $35 on Aldeyra (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>).</li><li>That tops Cantor's Elemer Piros, who earlier this morning gave ALDX a then Street-high target of $30. The data, says Piros, \"thoroughly impressed.\"</li><li>Shares are currently<font color='green'> up 43%</font>&nbsp;to $14.15.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392998-aldeyras-reproxalap-shows-positive-action-mid-stage-dry-eye-study-shares-ahead-6-percent\" target=\"_blank\">Aldeyra's reproxalap shows positive action in mid-stage dry eye study; shares ahead 6% premarket</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393155\" data-linked=\"Aldeyra +43%; Canaccord sees another 150% upside\" data-tweet=\"$ALDX - Aldeyra +43%; Canaccord sees another 150% upside https://seekingalpha.com/news/3393155-aldeyraplus-43-canaccord-sees-another-150-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3393155-aldeyraplus-43-canaccord-sees-another-150-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393151\" data-ts=\"1537977308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COG\" target=\"_blank\">COG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393151-cabot-oil-gas-downgraded-morgan-stanley-on-lower-nat-gas-price-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cabot Oil &amp; Gas downgraded at Morgan Stanley on lower nat gas price view</a></h4><ul>     <li>Cabot Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='red'>-2.8%</font>) slides after Morgan Stanley <a href=\"https://thefly.com/thestreet/realmoney/index.php/COG%3bRRC%3bGPOR%3bSWNid2795680/COG%3bRRC%3bGPOR%3bSWN-Morgan-Stanley-downgrades-Cabot-Oil-to-Equal-Weight-on-lower-nat-gas-price-view\" target=\"_blank\">downgrades</a> shares to Equal Weight from Overweight with a $23 price target, cut from $29, saying U.S. natural gas should soon enter a new cycle of structural oversupply and stagnating demand.</li>     <li>Stanley analyst Devin McDermott lowers his long-term natural gas price forecast to $2.50 from $2.75 and raises his price assumptions for ethane in late 2018 and 2019.</li><li>Given its view and the fact that oil weighted E&amp;Ps trade at similar multiples to natural gas producers, the firm remains Underweight on Range Resources (<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='red'>-3.8%</font>), Gulfport Energy (<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a> <font color='red'>-8.8%</font>) and Southwestern Energy (<a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='red'>-6.7%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3393151\" data-linked=\"Cabot Oil &amp; Gas downgraded at Morgan Stanley on lower nat gas price view\" data-tweet=\"$COG $COG $RRC - Cabot Oil &amp; Gas downgraded at Morgan Stanley on lower nat gas price view https://seekingalpha.com/news/3393151-cabot-oil-gas-downgraded-morgan-stanley-on-lower-nat-gas-price-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3393151-cabot-oil-gas-downgraded-morgan-stanley-on-lower-nat-gas-price-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393144\" data-ts=\"1537976845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATU\" target=\"_blank\">ATU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393144-actuant-down-7-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actuant down 7% post Q4 results</a></h4><ul><li>Actuant (<a href='https://seekingalpha.com/symbol/ATU' title='Actuant Corporation'>ATU</a> <font color='red'>-7.6%</font>)&nbsp;reported Q4 sales growth of 9.3% Y/Y to $301.4M. Segment sales: Industrial $111.6M (+11.3% Y/Y); Energy $77.45M (+13% Y/Y) and Engineered solutions $112.34M (+5.2% Y/Y).</li><li>Q4 Overall margins: Gross&nbsp;<font color='green'>improved by 90 bps</font>&nbsp;to 35.9%; Adj. operating&nbsp;<font color='green'>improved by 560 bps&nbsp;</font>to 10.7%;&nbsp;Adj. EBITDA<font color='green'> improved by 386 bps</font>&nbsp;to 14.3%.</li><li>Segment Adj. operating margin: Industrial was 23.8%&nbsp;<font color='red'>down by 20 bps</font>; Energy&nbsp;<font color='green'>recovered by 965 bps&nbsp;</font>to 4.3% and Engineered solutions 6.8%&nbsp;<font color='green'>up by 110 bps.</font></li><li>SG&amp;A expenses decrease by 1.4% Y/Y to $70.89M.</li><li>Net debt at August 31, 2018 was ~$282 million (total debt of $533M less $250M of cash). The ratio of net debt to proforma EBITDA leverage declined to 1.9 times.</li><li><strong>1Q19 Guidance</strong>: Sales $295-305M and Adj. EPS$0.20-0.25.</li><li><strong>FY19 Guidance:</strong> Sales $1.21-2.24B (growth of ~3-5%) and Adj. EPS $1.09-1.20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393047-actuant-beats-0_04-beats-revenue\" target=\"_blank\">Actuant beats by $0.04, beats on revenue</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393144\" data-linked=\"Actuant down 7% post Q4 results\" data-tweet=\"$ATU $EPAC - Actuant down 7% post Q4 results https://seekingalpha.com/news/3393144-actuant-down-7-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3393144-actuant-down-7-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393147\" data-ts=\"1537976604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393147-carmax-reverses-and-turns-lower-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax reverses and turns lower after earnings beat</a></h4><ul><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>) initially posted solid gains after topping top- and bottom-line estimates for Q2, but investors for now seem to be focusing on disappointing gross margins - 13.7% vs 14.1% estimated and 13.8% a year ago.</li><li>Shares are now&nbsp;<font color='red'>off 1.75%</font>&nbsp;on the session.</li><li>Other auto dealers: AutoNation (<a href='https://seekingalpha.com/symbol/AN' title='AutoNation Inc'>AN</a>), Lithia (<a href='https://seekingalpha.com/symbol/LAD' title='Lithia Motors, Inc.'>LAD</a> <font color='green'>+0.1%</font>), Carvana(<a href='https://seekingalpha.com/symbol/CVNA' title='Carvana Co.'>CVNA</a> <font color='green'>+5.8%</font>), Sonic (<a href='https://seekingalpha.com/symbol/SAH' title='Sonic Automotive Inc.'>SAH</a> <font color='red'>-0.3%</font>), Asbury (<a href='https://seekingalpha.com/symbol/ABG' title='Asbury Automotive Group, Inc.'>ABG</a> <font color='green'>+0.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393022-car-max-beat-q2-estimates\" target=\"_blank\">Car Max beats Q2 estimates</a> (Sept. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393011-carmax-beats-0_02-beats-revenue\" target=\"_blank\">CarMax beats by $0.02, beats on revenue</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393147\" data-linked=\"CarMax reverses and turns lower after earnings beat\" data-tweet=\"$KMX $KMX $AN - CarMax reverses and turns lower after earnings beat https://seekingalpha.com/news/3393147-carmax-reverses-and-turns-lower-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3393147-carmax-reverses-and-turns-lower-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393145\" data-ts=\"1537976314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOVX\" target=\"_blank\">GOVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393145-geovax-awarded-2_4m-from-u-s-department-of-defense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GeoVax awarded $2.4M from U.S. Department of Defense</a></h4><ul>     <li>GeoVax Labs (<a href='https://seekingalpha.com/symbol/GOVX' title='GeoVax Labs, Inc.'>OTCQB:GOVX</a> <font color='green'>+14.2%</font>) says that that the U.S. Department of Defense has awarded the Company a $2.44M cooperative agreement in support of its novel Lassa Fever vaccine development program.</li>     <li>In addition to the grant funds provided directly to GeoVax, DoD will also fund testing of the GeoVax vaccine by U.S. Army scientists under a separate subaward.</li>     <li><a href=\"https://seekingalpha.com/pr/17281772-geovax-awarded-2_4-million-u-s-department-defense-advance-lassa-fever-vaccine\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3393145\" data-linked=\"GeoVax awarded $2.4M from U.S. Department of Defense\" data-tweet=\"$GOVX - GeoVax awarded $2.4M from U.S. Department of Defense https://seekingalpha.com/news/3393145-geovax-awarded-2_4m-from-u-s-department-of-defense?source=tweet\" data-url=\"https://seekingalpha.com/news/3393145-geovax-awarded-2_4m-from-u-s-department-of-defense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393138\" data-ts=\"1537975460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCE\" target=\"_blank\">ARCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393138-arco-platform-expected-to-pop-on-ipo-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arco Platform expected to pop on IPO open</a></h4><ul> <li>Arco Platform (NASDAQ:<a href='https://seekingalpha.com/symbol/ARCE' title='Arco Platform'>ARCE</a>) is indicated to open trading at $23 after the company priced its IPO at $17.50.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3385672-brazils-arco-platform-files-ipo-nasdaq\" target=\"_blank\">Brazil's Arco Platform files for IPO on Nasdaq</a> (Aug. 24)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3392973-arco-platform-prices-initial-public-offering\" target=\"_blank\">Arco Platform prices initial public offering</a> (Sept. 26)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3393138\" data-linked=\"Arco Platform expected to pop on IPO open\" data-tweet=\"$ARCE - Arco Platform expected to pop on IPO open https://seekingalpha.com/news/3393138-arco-platform-expected-to-pop-on-ipo-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3393138-arco-platform-expected-to-pop-on-ipo-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393135\" data-ts=\"1537975063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVMK\" target=\"_blank\">SVMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393135-surveymonkey-rockets-on-ipo-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SurveyMonkey rockets on IPO open</a></h4><ul> <li>SurveyMonkey (NASDAQ:<a href='https://seekingalpha.com/symbol/SVMK' title='SurveyMonkey'>SVMK</a>) opens trading at $18.75 to sail past the $12.00 IPO pricing level.</li> <li>The company set an original pricing range of $9 to $11 before bumping it up for the official pricing.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392936-cnbc-surveymonkey-prices-ipo-range-12-share-updated\" target=\"_blank\">CNBC: SurveyMonkey prices IPO above range at $12/share (updated)</a> (Sept. 25)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3389923-surveymonkey-updates-ipo\" target=\"_blank\">SurveyMonkey updates on IPO</a> (Sept. 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3393135\" data-linked=\"SurveyMonkey rockets on IPO open\" data-tweet=\"$SVMK - SurveyMonkey rockets on IPO open https://seekingalpha.com/news/3393135-surveymonkey-rockets-on-ipo-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3393135-surveymonkey-rockets-on-ipo-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393134\" data-ts=\"1537974851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393134-aveo-pharma-continues-up-move-shares-ahead-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVEO Pharma continues up move, shares ahead 7%</a></h4><ul><li>AVEO Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color='green'>+7%</font>) is up on 72% higher volume. Shares have rallied&nbsp;<font color='green'>87%&nbsp;</font>since touching $1.86 on July 18 as the stock builds the right side of a year-long base.</li><li>A key upcoming event is the release of topline data from its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02627963?lead=aveo&amp;phase=2&amp;rank=1\" target=\"_blank\">TIVO-3</a> study evaluating tivozanib in patients with advanced kidney cancer, expected in Q4.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3371414-aveo-oncology-revises-tivominus-3-trial-guidance\" target=\"_blank\">AVEO oncology revises TIVO-3 trial guidance</a> (July 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393134\" data-linked=\"AVEO Pharma continues up move, shares ahead 7%\" data-tweet=\"$AVEO - AVEO Pharma continues up move, shares ahead 7% https://seekingalpha.com/news/3393134-aveo-pharma-continues-up-move-shares-ahead-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3393134-aveo-pharma-continues-up-move-shares-ahead-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393131\" data-ts=\"1537974173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRUP\" target=\"_blank\">TRUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393131-trupanion-down-5-on-report-of-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trupanion down more than 5% on report of probe</a></h4><ul><li><a href=\"https://thecapitolforum.com/#\" target=\"_blank\">According to Capitol Forum</a>, Trupanion (<a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='red'>-5.6%</font>) is under investigation by the New York Department of Financial Services.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393131\" data-linked=\"Trupanion down more than 5% on report of probe\" data-tweet=\"$TRUP - Trupanion down more than 5% on report of probe https://seekingalpha.com/news/3393131-trupanion-down-5-on-report-of-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3393131-trupanion-down-5-on-report-of-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393129\" data-ts=\"1537974097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393129-healthcare-top-5-gainers-losers-of-11-00-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/26/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics'>OBLN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NITE' title='Nightstar Therapeutics plc'>NITE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393129\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/26/2018)\" data-tweet=\"$ALDX $ALDX $ELMD - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/26/2018) https://seekingalpha.com/news/3393129-healthcare-top-5-gainers-losers-of-11-00-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393129-healthcare-top-5-gainers-losers-of-11-00-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393128\" data-ts=\"1537974063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTWK\" target=\"_blank\">NTWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393128-netsol-technologies-down-7_1-despite-strong-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetSol Technologies down 7.1% despite strong Q4 results</a></h4><ul><li>NetSol Technologies (<a href='https://seekingalpha.com/symbol/NTWK' title='NetSol Technologies Inc.'>NTWK</a> <font color='red'>-7.1%</font>) <a href=\"https://seekingalpha.com/pr/17281394-netsol-technologies-reports-fiscal-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">reports Q4</a> net sales of $16.6M (+14.8% Y/Y) of which, license fees were $3.4M (+3% Y/Y); maintenance fees were $3.8M (+5.6% Y/Y) &amp; services revenues were $9.4M (+23.7% Y/Y).</li><li>Gross margin&nbsp;<font color='green'>increased 1,950 bps</font>&nbsp;to 51.2%.</li><li>Adj. EBITDA was $2.9M, an improvement from a loss of $0.85M Y/Y.</li><li>Operating expenses decreased 6% Y/Y to $7.4M.</li><li>Cash and equivalents were $22.1M (+55.6% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393012-netsol-reports-q4-results\" target=\"_blank\">NetSol reports Q4 results</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393128\" data-linked=\"NetSol Technologies down 7.1% despite strong Q4 results\" data-tweet=\"$NTWK - NetSol Technologies down 7.1% despite strong Q4 results https://seekingalpha.com/news/3393128-netsol-technologies-down-7_1-despite-strong-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3393128-netsol-technologies-down-7_1-despite-strong-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393126\" data-ts=\"1537973700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393126-alcoa-union-meeting-again-over-strike-australian-aluminum-operations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa, union meeting again over strike at Australian aluminum operations</a></h4><ul>     <li>The union at Alcoa&rsquo;s (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-3.4%</font>) aluminum operations in Western Australia state says it <a href=\"https://www.reuters.com/article/australia-alcoa-strike/union-says-meeting-with-alcoa-again-over-strike-at-australian-aluminium-project-idUSL4N1WC14S\" target=\"_blank\">will meet with the company again</a> to attempt to resolve a strike that has lasted more than six weeks.</li><li>Union workers at two alumina refineries and three bauxite mines  walked out on Aug. 8 over concerns that a new workplace agreement did not  adequately address job security.</li><li>Alcoa said earlier this month that production of alumina at the site had been  cut by a total of ~15K metric tons in August vs. normal annual output of ~9M metric tons, or 25K metric tons/day.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a>, <a href='https://seekingalpha.com/symbol/JJUB' title='iPath Series B Bloomberg Aluminum Subindex Total Return ETN'>JJUB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3393126\" data-linked=\"Alcoa, union meeting again over strike at Australian aluminum operations\" data-tweet=\"$AA $AA $FOIL - Alcoa, union meeting again over strike at Australian aluminum operations https://seekingalpha.com/news/3393126-alcoa-union-meeting-again-over-strike-australian-aluminum-operations?source=tweet\" data-url=\"https://seekingalpha.com/news/3393126-alcoa-union-meeting-again-over-strike-australian-aluminum-operations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393125\" data-ts=\"1537973365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393125-viacom-gains-cbs-re-merger-seen-likely-in-time\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom gains as CBS re-merger seen more likely in time</a></h4><ul>   <li>Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+2.9%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+3.3%</font>) is rising amid morning talk about likelihood of its (eventual) re-merger with <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>.</li>    <li>CNBC's David Faber says advisers to the companies note nothing's going on right now, but \"next year it is certainly not inconceivable that these two companies would potentially re-engage.\"</li>    <li>Meanwhile, B. Riley sees the two as among the next up for consolidation, now that a corporate governance mess is largely behind them. A deal in the next two years is the most probable outcome, analyst Barton Crockett says, with cost synergies that could top $1.3B -- and faster upside the faster the deal comes together. (h/t Bloomberg)</li>    <li>Crockett's boosting his <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> target to $39 from $34 (now implying 16.3% upside), and reaffirming <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> at Buy with a price target raised to $63 from $61 (11.6% upside).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393125\" data-linked=\"Viacom gains as CBS re-merger seen more likely in time\" data-tweet=\"$VIA $VIA $VIAB - Viacom gains as CBS re-merger seen more likely in time https://seekingalpha.com/news/3393125-viacom-gains-cbs-re-merger-seen-likely-in-time?source=tweet\" data-url=\"https://seekingalpha.com/news/3393125-viacom-gains-cbs-re-merger-seen-likely-in-time\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393124\" data-ts=\"1537973292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBLN\" target=\"_blank\">OBLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393124-obalon-up-15-on-fda-nod-for-automated-gastric-balloon-inflator\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obalon up 15% on FDA nod for automated gastric balloon inflator</a></h4><ul><li>Thinly traded nano cap Obalon Therapeutics (<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics'>OBLN</a> <font color='green'>+14.5%</font>) is up on 34% higher volume in response its <a href=\"https://seekingalpha.com/pr/17281909-fda-grants-pma-s-approval-obalon-touch-inflation-system\" target=\"_blank\">announcement</a> that the FDA has approved its Obalon Touch Inflation System used to inflate its <a href=\"https://www.obalon.com/what-is-obalon-balloon-system/\" target=\"_blank\">Obalon Balloon</a>.</li><li>The company says the automated inflation system should be used with the Obalon Navigation System (not yet approved in the U.S.) which is designed to eliminate the need for X-ray imaging during balloon placement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393124\" data-linked=\"Obalon up 15% on FDA nod for automated gastric balloon inflator\" data-tweet=\"$OBLN - Obalon up 15% on FDA nod for automated gastric balloon inflator https://seekingalpha.com/news/3393124-obalon-up-15-on-fda-nod-for-automated-gastric-balloon-inflator?source=tweet\" data-url=\"https://seekingalpha.com/news/3393124-obalon-up-15-on-fda-nod-for-automated-gastric-balloon-inflator\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393118\" data-ts=\"1537973181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESNC\" target=\"_blank\">ESNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393118-ensync-slips-9-post-q4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnSync slips 9% post Q4 earnings miss</a></h4><ul><li>EnSync (<a href='https://seekingalpha.com/symbol/ESNC' title='EnSync, Inc.'>ESNC</a> <font color='red'>-9.9%</font>) reported Q4 revenue decrease of 46% Y/Y to $1.65M, impacted by the sale and construction delays for three PPA projects.</li><li>Q4 Gross margin&nbsp;<font color='red'>declined by 150 bps&nbsp;</font>to 4% and Adj. Gross margin was 21.9% compared to 3.8% a year ago.</li><li>SG&amp;A expenses were $2.69M a decrease of 3.1% Y/Y.</li><li>Company has a backlog of ~$16.4M, as of date.</li><li>Net inventories were $1.22M (-50.8% Y/Y). Net cash used in operating activities for the fiscal year was $10.16M compared to $7.21M a year ago.</li><li>Cash and cash equivalents $3M as of June 30, 2018. Company received net proceeds of $2.7M, on completing the registered direct offering&nbsp;of a maximum shares currently available under its shelf registration,11.3M shares at a price of $0.26 per share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392887-ensync-misses-0_02-misses-revenue\" target=\"_blank\">EnSync misses by $0.02, misses on revenue</a> (Sept. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393118\" data-linked=\"EnSync slips 9% post Q4 earnings miss\" data-tweet=\"$ESNC - EnSync slips 9% post Q4 earnings miss https://seekingalpha.com/news/3393118-ensync-slips-9-post-q4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3393118-ensync-slips-9-post-q4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393121\" data-ts=\"1537972976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEF\" target=\"_blank\">CHEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393121-chefs-warehouse-down-2-after-jefferies-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chef&#39;s Warehouse down 2% after Jefferies cut</a></h4><ul> <li>Chef's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEF' title='Chefs&#39; Warehouse'>CHEF</a>) is <font color='red'>down 2.2%</font> in early trading after Jefferies warns on valuation.</li> <li>The Jefferies team sees potential for the company to expand margins over the long term, but sees the two-year rally pushing up earnings multiples to a peak for the near term.</li><li>Chef's is lowered by Jefferies to a Hold rating from Buy.</li> <li>Shares of Chefs' Warehouse are up 87% over the last 52 weeks.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3393121\" data-linked=\"Chef&#39;s Warehouse down 2% after Jefferies cut\" data-tweet=\"$CHEF - Chef&#39;s Warehouse down 2% after Jefferies cut https://seekingalpha.com/news/3393121-chefs-warehouse-down-2-after-jefferies-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3393121-chefs-warehouse-down-2-after-jefferies-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393117\" data-ts=\"1537972621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393117-profit-taking-pressures-jaguar-health-down-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Profit-taking pressures Jaguar Health, down 21%</a></h4><ul><li>Nano cap Jaguar Health (<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-21.4%</font>) is down on triple normal as investors bag profits from yesterday's&nbsp;<font color='green'>158%</font>&nbsp;move. Shares jumped in reaction to its out-licensing deal with Knight Therapeutics for Mytesi (crofelemer) in Canada and Israel. Knight also has the right of first negotiation to commercialize Mytesi and related products in certain Latin American countries.</li><li>Under the terms of the <a href=\"https://seekingalpha.com/pr/17279097-knight-therapeutics-jaguar-health-announce-strategic-partnership\" target=\"_blank\">agreement</a>, Jaguar may earn up to ~$18M in regulatory and sales-based milestones over the 15-year term of the contract.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393117\" data-linked=\"Profit-taking pressures Jaguar Health, down 21%\" data-tweet=\"$JAGX - Profit-taking pressures Jaguar Health, down 21% https://seekingalpha.com/news/3393117-profit-taking-pressures-jaguar-health-down-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3393117-profit-taking-pressures-jaguar-health-down-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393116\" data-ts=\"1537972285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393116-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude +<strong>1.9</strong><strong>M</strong> barrels vs. -1.3M consensus, -2.1M last week.</li><li>Gasoline <strong>+1.5M</strong> barrels vs. +0.8M consensus, -1.7M last week.</li><li>Distillates -<strong>2.2</strong><strong>M</strong> barrels vs. +0.8M consensus, +0.8M last week.</li><li>Futures&nbsp;<font color='red'>-0.58%</font>&nbsp;to $71.86.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3393116\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3393116-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3393116-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393114\" data-ts=\"1537972141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELMD\" target=\"_blank\">ELMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393114-electromed-up-18-on-fq4-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Electromed up 18% on FQ4 earnings</a></h4><ul><li>Thinly traded nano cap Electromed (<a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='green'>+17.6%</font>) is up on a healthy 35x surge in volume, albeit on turnover of only 472K shares, in response to its <a href=\"https://seekingalpha.com/pr/17280968-electromed-inc-announces-fiscal-2018-fourth-quarter-financial-results\" target=\"_blank\">fiscal Q4 results</a> released after yesterday's close.</li><li>Revenue was up 13% to $8.2M and net income jumped 18% to $1.1M. Cash flow ops was up 48% to $570K.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393114\" data-linked=\"Electromed up 18% on FQ4 earnings\" data-tweet=\"$ELMD - Electromed up 18% on FQ4 earnings https://seekingalpha.com/news/3393114-electromed-up-18-on-fq4-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3393114-electromed-up-18-on-fq4-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393106\" data-ts=\"1537971155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETTX\" target=\"_blank\">ETTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393106-ipo-entasis-therapeutics-opens-13_45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IPO Entasis Therapeutics opens at $13.45</a></h4><ul><li>IPO <a href=\"http://www.entasistx.com/\" target=\"_blank\">Entasis Therapeutics</a> (<a href='https://seekingalpha.com/symbol/ETTX' title='Entasis Therapeutics'>ETTX</a> <font color='red'>N/A</font>) opened at $13.45, below its offering price of $15.</li><li>The Waltham, MA-based biopharmaceutical firm <a href=\"https://www.sec.gov/Archives/edgar/data/1724344/000104746918005679/a2236470zs-1.htm\" target=\"_blank\">develops antibiotics</a> to treat serious infections. Lead candidate is ETX2514, a&nbsp;beta-lactam antibiotic.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393106\" data-linked=\"IPO Entasis Therapeutics opens at $13.45\" data-tweet=\"$ETTX - IPO Entasis Therapeutics opens at $13.45 https://seekingalpha.com/news/3393106-ipo-entasis-therapeutics-opens-13_45?source=tweet\" data-url=\"https://seekingalpha.com/news/3393106-ipo-entasis-therapeutics-opens-13_45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393105\" data-ts=\"1537971034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYF\" target=\"_blank\">SYF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393105-synchrony-financialminus-1_8-after-bofaml-cuts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchrony Financial -1.8% after BofAML cuts to neutral</a></h4><ul><li>Synchrony Financial (NYSE:<a href='https://seekingalpha.com/symbol/SYF' title='Synchrony Financial'>SYF</a>)&nbsp;<font color='red'>falls 1.8%</font>&nbsp;after Bank of America Merrill Lynch analyst Kenneth Bruce cuts the stock to neutral from buy on lingering renewal risk concerns.</li><li>Even with Lowe's extending its partnership with Synchrony, upside potential is limited, Bruce writes in a note.</li><li>If renewal risk becomes less of a concern and/or investors gain more confidence in Synchrony's earnings prospects, re-rating SYF to peer multiples of about 9x '19 EPS est. brings stock to about $38, an upside potential of about 15% to Tuesday's close.</li><li>Bruce sees Synchrony offsetting the loss of the Walmart agreement with buybacks and growth from the rest of its portfolio. Loss of the Walmart business may also result in lower loss rates, he wrote.</li><li>Source: Bloomberg First Word.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3382605-analysts-weigh-lowes-renewing-synchrony-credit-pact\" target=\"_blank\">Analysts weigh in on Lowe's renewing Synchrony credit pact</a> (Aug. 14)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3382291-lowes-synchrony-extend-credit-partnership\" target=\"_blank\">Lowe's, Synchrony extend credit partnership</a> (Aug. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393105\" data-linked=\"Synchrony Financial -1.8% after BofAML cuts to neutral\" data-tweet=\"$SYF - Synchrony Financial -1.8% after BofAML cuts to neutral https://seekingalpha.com/news/3393105-synchrony-financialminus-1_8-after-bofaml-cuts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3393105-synchrony-financialminus-1_8-after-bofaml-cuts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393102\" data-ts=\"1537970721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTAS\" target=\"_blank\">CTAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393102-cintas-declined-4_7-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cintas declined 4.7% post Q1 results</a></h4><ul><li>Cintas (<a href='https://seekingalpha.com/symbol/CTAS' title='Cintas Corporation'>CTAS</a> <font color='red'>-4.7%</font>) <a href=\"https://seekingalpha.com/filing/4179195\" target=\"_blank\">reports Q1</a> net sales of $1.69B (+5% Y/Y).</li><li>Q1 organic revenue growth of      5.2%, led by 4.9% growth in Uniform Rental &amp;&nbsp;Facility Services      sales and 9% increase First Aid &amp; Safety Services revenues.</li><li>Operating margin&nbsp;<font color='green'>increased 16 bps</font>&nbsp;to 15.61%.</li><li>Management guides FY19 sales      of $6.80B-6.86B and EPS from continuing operations of $7.19- $7.29; the      company expects G&amp;K integration expenses to be ~$15M-20M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392893-cintas-beats-0_13-beats-revenue\" target=\"_blank\">Cintas beats by $0.13, beats on revenue</a> (Sept. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393102\" data-linked=\"Cintas declined 4.7% post Q1 results\" data-tweet=\"$CTAS - Cintas declined 4.7% post Q1 results https://seekingalpha.com/news/3393102-cintas-declined-4_7-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3393102-cintas-declined-4_7-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393099\" data-ts=\"1537970321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393099-seagate-bull-trims-price-target-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seagate bull trims price target; shares down 3%</a></h4><ul><li>While NAND pricing concerns are \"overblown,\" cloud could be a larger near-term risk, says Morgan Stanley's Katy Huberty, cutting her price target on Seagate (NASDAQ:<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>) from a Street-high $78 to $73.</li><li>She cuts her fiscal 2019 EPS estimate to $6.07 from $6.50, and vs the Street at $6.21.</li><li>Source: Bloomberg</li><li>Shares are&nbsp;<font color='red'>down 3.1%</font>&nbsp;to $46.99.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393099\" data-linked=\"Seagate bull trims price target; shares down 3%\" data-tweet=\"$STX - Seagate bull trims price target; shares down 3% https://seekingalpha.com/news/3393099-seagate-bull-trims-price-target-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3393099-seagate-bull-trims-price-target-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393097\" data-ts=\"1537970262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTA\" target=\"_blank\">CMTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393097-clementia-pharma-down-9-on-updated-mid-stage-paloverotene-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clementia Pharma down 9% on updated mid-stage paloverotene data</a></h4><ul><li>Thinly traded micro cap Clementia Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CMTA' title='Clementia Pharmaceuticals'>CMTA</a> <font color='red'>-9.4%</font>) is down on light volume in apparent reaction to its <a href=\"https://seekingalpha.com/pr/17281644-clementia-announces-updated-phase-2-part-b-data-palovarotene-fop\" target=\"_blank\">announcement </a>of updated results from the open-label extension of its Phase 2 clinical trial evaluating paloverotene in patients with <a href=\"https://ghr.nlm.nih.gov/condition/fibrodysplasia-ossificans-progressiva\" target=\"_blank\">fibrodysplasia ossificans progressiva</a> &#40;FOP&#41;, an inherited disorder characterized by the gradual replacement of tendons and ligaments with bone. The data were presented at the Mechanistic and Therapeutic Advances in Rare Skeletal Diseases meeting in Montreal.</li><li>12-week flare-up imaging data showed treatment with paloverotene reduced mean new bone growth ~73% compared to placebo. In May, the company reported a 91% reduction in new bone growth.</li><li>A Phase 3 trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03312634?lead=clementia&amp;phase=2&amp;rank=1\" target=\"_blank\">MOVE</a>, is in process with data readouts expected in Q2 and Q3 of next year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358976-clementia-pharmas-palovarotene-shows-positive-effect-mid-stage-fop-study\" target=\"_blank\">Clementia Pharma's palovarotene shows positive effect in mid-stage FOP study</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393097\" data-linked=\"Clementia Pharma down 9% on updated mid-stage paloverotene data\" data-tweet=\"$CMTA - Clementia Pharma down 9% on updated mid-stage paloverotene data https://seekingalpha.com/news/3393097-clementia-pharma-down-9-on-updated-mid-stage-paloverotene-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3393097-clementia-pharma-down-9-on-updated-mid-stage-paloverotene-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393074\" data-ts=\"1537968399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MANH\" target=\"_blank\">MANH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393074-manhattan-associatesminus-4_2-suntrust-moving-to-sideline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manhattan Associates -4.2% with SunTrust moving to sideline</a></h4><ul>   <li>Manhattan Associates (NASDAQ:<a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a>) is <font color='red'>4.2% lower</font> premarket after a cut to Hold at SunTrust Robinson Humphrey, which is pointing to more balanced risk/reward ratios after recent movement.</li>    <li>The firm's set its price target to $57, implying 1.1% upside.</li>    <li>Shares have been on a six-month run of <font color='green'>+36.4%</font>, leading in large part to SunTrust's re-evaluation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393074\" data-linked=\"Manhattan Associates -4.2% with SunTrust moving to sideline\" data-tweet=\"$MANH - Manhattan Associates -4.2% with SunTrust moving to sideline https://seekingalpha.com/news/3393074-manhattan-associatesminus-4_2-suntrust-moving-to-sideline?source=tweet\" data-url=\"https://seekingalpha.com/news/3393074-manhattan-associatesminus-4_2-suntrust-moving-to-sideline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393072\" data-ts=\"1537968240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393072-premarket-gainers-of-9-05-09-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (09/26/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3392998-aldeyras-reproxalap-shows-positive-action-mid-stage-dry-eye-study-shares-ahead-6-percent\" target=\"_blank\">positive action</a> in mid-stage dry eye study.</li><li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+27%</font>&nbsp;to <a href=\"https://seekingalpha.com/pr/17281109-igc-enter-hemp-cbd-infused-energy-drink-space\" target=\"_blank\">enter</a> the Hemp/CBD-Infused Energy Drink space.</li><li><a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a> <font color='green'>+16%</font>.</li><li><a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17281707-size-launches-mysizeid-smart-measurement-fashion-app-ios\" target=\"_blank\">launches</a> MySizeID&trade; Smart Measurement Fashion App for iOS.</li><li><a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='green'>+15%</font>.</li><li><a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3392922-vaalco-energy-announces-extension-etame-exclusive-exploitation-areas-2028\" target=\"_blank\">extension</a> of Etame Exclusive Exploitation Areas Through 2028.</li><li><a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='green'>+10%</font>&nbsp;on positive analyst <a href=\"https://seekingalpha.com/news/3393053-premarket-analyst-action\" target=\"_blank\">action</a>.</li><li><a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3393056-t2-biosystems-9-percent-premarket-positive-data-supporting-t2lyme-panel\" target=\"_blank\">positive</a> data supporting T2Lyme Panel.</li><li><a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+8%</font>&nbsp;on duvelisib <a href=\"https://seekingalpha.com/news/3392899-verastem-5-percent-hours-duvelisib-deal-china\" target=\"_blank\">deal</a> in&nbsp;China.</li><li><a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+7%&nbsp;</font>as imperial brands at cannabis <a href=\"https://seekingalpha.com/news/3393039-imperial-brands-hints-cannabis-interest\" target=\"_blank\">market</a>.</li><li><a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+6%</font>&nbsp;on $12M supply <a href=\"https://seekingalpha.com/news/3392992-supreme-cannabis-inks-12m-supply-deal-tilray\" target=\"_blank\">deal</a> with Supreme Cannabis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393072\" data-linked=\"Premarket Gainers as of 9:05 am (09/26/2018)\" data-tweet=\"$ALDX $ALDX $IGC - Premarket Gainers as of 9:05 am (09/26/2018) https://seekingalpha.com/news/3393072-premarket-gainers-of-9-05-09-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393072-premarket-gainers-of-9-05-09-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393069\" data-ts=\"1537968047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393069-digital-ally-slumps-15-after-stock-offering-prices-3_05-per-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Ally slumps 15% after stock offering prices at $3.05 per share</a></h4><ul><li>Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>)<font color='red'> sinks 15%</font>&nbsp;in premarket trading after its offering of 2.4M shares of common stock<a href=\"https://seekingalpha.com/pr/17281724-digital-ally-inc-prices-underwritten-public-offering-common-stock\" target=\"_blank\"> prices</a> at $3.05 per share.</li><li>DGLY fell 12% on Tuesday to close regular-hours trading at $3.55.</li><li>The company expects net proceeds of about $6.75M, excluding the exercise of the overallotment option for 360,000 more shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392904-digital-ally-dips-announced-share-offering\" target=\"_blank\">Digital Ally dips further on announced share offering</a> (Sept. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393069\" data-linked=\"Digital Ally slumps 15% after stock offering prices at $3.05 per share\" data-tweet=\"$DGLY - Digital Ally slumps 15% after stock offering prices at $3.05 per share https://seekingalpha.com/news/3393069-digital-ally-slumps-15-after-stock-offering-prices-3_05-per-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3393069-digital-ally-slumps-15-after-stock-offering-prices-3_05-per-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393068\" data-ts=\"1537967891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCLP\" target=\"_blank\">HCLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393068-hi-crush-partners-temporarily-idles-whitehall-dry-plant-operations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hi-Crush Partners temporarily idles Whitehall dry plant operations</a></h4><ul>     <li>Hi-Crush Partners (NYSE:<a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a>) <font color='red'>-2.4%</font> pre-market after saying it has <a href=\"https://seekingalpha.com/pr/17281709-hi-crush-announces-temporary-idling-whitehall-dry-plant\" target=\"_blank\">temporarily idled dry plant operations</a> at its Whitehall facility in Wisconsin, citing \"recent, temporary softness\" in completions activity and frac sand demand.</li>     <li>HCLP says Whitehall's wet plant remains operational and continues to sell inventory from on-site storage to meet ongoing Northern White customer demand; wet and dry plants remain operational at the company's other Wisconsin mines.</li>     <li>HCLP says the reduced level of expected activity  is reflected in previous Q3 guidance for sales volumes of 2.8M-3M tons, and it expects strong demand for Northern White and in-basin Permian sand in 2019 and beyond.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393068\" data-linked=\"Hi-Crush Partners temporarily idles Whitehall dry plant operations\" data-tweet=\"$HCLP $HCR - Hi-Crush Partners temporarily idles Whitehall dry plant operations https://seekingalpha.com/news/3393068-hi-crush-partners-temporarily-idles-whitehall-dry-plant-operations?source=tweet\" data-url=\"https://seekingalpha.com/news/3393068-hi-crush-partners-temporarily-idles-whitehall-dry-plant-operations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393064\" data-ts=\"1537967603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393064-cienaminus-2_6-ubs-cuts-to-neutral-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena -2.6% as UBS cuts to Neutral on valuation</a></h4><ul>   <li>Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) is <font color='red'>2.6% lower</font> premarket after a downgrade to Neutral at UBS, which points to the market better understanding the company's sales momentum.</li>    <li>Deployments should contribute to revenue growth over several quarters, but that's partly offset by tougher comparisons along with tougher webscale competition based on 600 Gbps technology, analyst Tejas Venkatesh writes. Growth in India and webscale may not be sustainable. (h/t Bloomberg)</li>    <li>Venkatesh has a price target updated to $33, implying 5.4% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393064\" data-linked=\"Ciena -2.6% as UBS cuts to Neutral on valuation\" data-tweet=\"$CIEN - Ciena -2.6% as UBS cuts to Neutral on valuation https://seekingalpha.com/news/3393064-cienaminus-2_6-ubs-cuts-to-neutral-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3393064-cienaminus-2_6-ubs-cuts-to-neutral-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393062\" data-ts=\"1537967378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPAY\" target=\"_blank\">FPAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393062-premarket-losers-of-9-05-9-26-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (9/26/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a>&nbsp;<font color='red'>-28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3392978-flexshopper-prices-10m-public-offering-shares-19-percent-premarket\" target=\"_blank\">pricing</a> $10M public offering.</li><li><a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-18%</font>.</li><li><a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3392904-digital-ally-dips-announced-share-offering\" target=\"_blank\">announcing</a> public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a>&nbsp;<font color='red'>-13%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3392934-ultra-petroleum-minus-25-percent-failing-reach-terms-lenders\" target=\"_blank\">failing</a> to reach terms with lenders.</li><li><a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3393062\" data-linked=\"Premarket Losers as of 9:05 am (9/26/2018)\" data-tweet=\"$FPAY $FPAY $JAGX - Premarket Losers as of 9:05 am (9/26/2018) https://seekingalpha.com/news/3393062-premarket-losers-of-9-05-9-26-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3393062-premarket-losers-of-9-05-9-26-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393056\" data-ts=\"1537966782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTOO\" target=\"_blank\">TTOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393056-t2-biosystems-up-9-premarket-on-positive-data-supporting-t2lyme-panel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T2 Biosystems up 9% premarket on positive data supporting T2Lyme Panel</a></h4><ul><li>T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17281341-new-data-suggests-t2-biosystems-t2lyme-panel-accurate-diagnostics-identifying-borrelia\" target=\"_blank\">announcement </a>of preclinical data that suggests its T2Lyme Panel is more accurate than other methods for identifying <em>Borrelia </em>infections in people with suspected early-stage Lyme disease. The data were presented at the International Conference on Lyme Borreliosis and Other Tick-Borne Diseases in Atlanta, GA.</li><li>Results from a preclinical study involving 21 patients with an <a href=\"https://www.healthline.com/health/erythema-migrans\" target=\"_blank\">erythema migrans</a> rash (circular rash that often appears in the early stages of Lyme disease) showed a 78% positive percent agreement &#40;PPA&#41;&nbsp;with tissue culture and 100% negative percent agreement &#40;NPA&#41;. The currently recommended diagnostic, two-tier serology, showed a 56% PPA and 92% NPA. Polymerase chain reaction &#40;PCR&#41; did not correctly identify any positives.</li><li>The company is currently enrolling patients in a pivotal study evaluating the T2Lyme Panel that should be completed next year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393056\" data-linked=\"T2 Biosystems up 9% premarket on positive data supporting T2Lyme Panel\" data-tweet=\"$TTOO - T2 Biosystems up 9% premarket on positive data supporting T2Lyme Panel https://seekingalpha.com/news/3393056-t2-biosystems-up-9-premarket-on-positive-data-supporting-t2lyme-panel?source=tweet\" data-url=\"https://seekingalpha.com/news/3393056-t2-biosystems-up-9-premarket-on-positive-data-supporting-t2lyme-panel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393054\" data-ts=\"1537966012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTB\" target=\"_blank\">MTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393054-m-and-t-bank-gains-1_4-goldman-upgrades-on-interest-rate-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">M&amp;T Bank gains 1.4% as Goldman upgrades on interest-rate outlook</a></h4><ul><li>M&amp;T Bank (NYSE:<a href='https://seekingalpha.com/symbol/MTB' title='M&T Bank Corporation'>MTB</a>)<font color='green'> rises 1.4%</font>&nbsp;in premarket trading after Goldman analyst Ryan Nash raises the bank to a buy after analyzing implications of further interest-rate hikes on banks' deposit bases, needs for more deposit funding, and deposit betas.</li><li>Nash expects two more interest-rate hikes for the rest of this year and four in 2020.</li><li>Reiterates top picks of Comerica (NYSE:<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Inc.'>CMA</a>), Regions Financial (NYSE:<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a>), SunTrust Banks (NYSE:<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a>), Citizens Financial Group (NYSE:<a href='https://seekingalpha.com/symbol/CFG' title='Citizens Financial Group'>CFG</a>), and KeyCorp (NYSE:<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a>).</li><li>Source: Bloomberg First Word.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392951-fomc-expected-lift-rates\" target=\"_blank\">FOMC expected to lift rates</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393054\" data-linked=\"M&amp;T Bank gains 1.4% as Goldman upgrades on interest-rate outlook\" data-tweet=\"$MTB $MTB $CMA - M&amp;T Bank gains 1.4% as Goldman upgrades on interest-rate outlook https://seekingalpha.com/news/3393054-m-and-t-bank-gains-1_4-goldman-upgrades-on-interest-rate-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3393054-m-and-t-bank-gains-1_4-goldman-upgrades-on-interest-rate-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393053\" data-ts=\"1537965785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393053-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action</a></h4><ul><li>Juniper Networks (NYSE:<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks'>JNPR</a>) initiated with Neutral rating and $31 (4% upside) price target at UBS.</li><li>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) initiated with Buy rating at William O'Neil &amp; Co.</li><li>Carnival (NYSE:<a href='https://seekingalpha.com/symbol/CCL' title='Carnival Corporation'>CCL</a>) resumed with Buy rating and $78 (17% upside) price target at BofA/Merrill Lynch. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Arista Networks (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) upgraded to Neutral with a $290 (6% upside) price target at UBS.</li><li>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>) upgraded to Outperform with a $9 (36% upside) price target at Oppenheimer. Shares up<font color='green'> 8%</font>&nbsp;premarket.</li><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) upgraded to Buy with a $180 (21% upside) price target at UBS. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li><li>Viacom (NASDAQ:<a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>) upgraded to Buy with a $39 (20% upside) price target at B. Riley FBR. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) downgraded to Neutral with a $33 (5% upside) price target at UBS. Shares down&nbsp;<font color='red'>3%&nbsp;</font>premarket.</li><li>Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) downgraded to Neutral with a $170 (12% upside) price target at UBS. Shares down&nbsp;<font color='red'>2%</font>&nbsp;premarket.</li><li>Manhattan Associates (NASDAQ:<a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a>) downgraded to Hold with a $57 (1% upside) price target at SunTrust.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393053\" data-linked=\"Premarket analyst action\" data-tweet=\"$JNPR $JNPR $YELP - Premarket analyst action https://seekingalpha.com/news/3393053-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3393053-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393045\" data-ts=\"1537965033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRTS\" target=\"_blank\">SRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393045-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Sensus Healthcare (NASDAQ:<a href='https://seekingalpha.com/symbol/SRTS' title='Sensus Healthcare'>SRTS</a>) initiated with Buy rating and $12.50 (58% upside) price target at B. Riley FBR.</li><li>Repligen (NASDAQ:<a href='https://seekingalpha.com/symbol/RGEN' title='Repligen Corporation'>RGEN</a>) initiated with Neutral rating and $49 (10% downside risk) price target at H.C. Wainwright.</li><li>Elanco Animal Health (NYSE:<a href='https://seekingalpha.com/symbol/ELAN' title='Elanco'>ELAN</a>) initiated with Market Perform rating and $33 (5% downside risk) price target at BMO Capital Markets.</li><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) resumed with Overweight rating and $117 (11% upside) price target at JPMorgan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393045\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$SRTS $SRTS $RGEN - Premarket analyst action - healthcare https://seekingalpha.com/news/3393045-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3393045-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393041\" data-ts=\"1537964608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393041-ibmplus-1_7-premarket-after-upgrade-ubs-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM +1.7% premarket after upgrade by UBS to buy</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>)<font color='green'> gains 1.7%</font>&nbsp;in premarket actions after UBS analyst John Roy raises his rating on the stock to buy from neutral, saying that consensus revenue estimate of a 0.2% decline is beatable.</li><li>Furthermore, a sum-of-the-parts analysts indicates the market isn't applying any value to IBM's hardware business, he writes.</li><li>He sees operating margin improving by 130 basis points on stronger services performance.</li><li>Roy raises price target to $180 from $160.</li><li>Source: Bloomberg First Word.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392531-walmart-will-require-suppliers-use-ibms-food-safety-solution\" target=\"_blank\">Walmart will require some suppliers to use IBM's food safety solution</a> (Sept. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393041\" data-linked=\"IBM +1.7% premarket after upgrade by UBS to buy\" data-tweet=\"$IBM - IBM +1.7% premarket after upgrade by UBS to buy https://seekingalpha.com/news/3393041-ibmplus-1_7-premarket-after-upgrade-ubs-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3393041-ibmplus-1_7-premarket-after-upgrade-ubs-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393022\" data-ts=\"1537963206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393022-car-max-beat-q2-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Car Max beat Q2 estimates</a></h4><ul><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>) reports used vehicles unit sales rose 5.8% to 196,880, and +2.1% on a comparable-store basis&nbsp;in <a href=\"https://seekingalpha.com/pr/17281399-carmax-reports-second-quarter-results\" target=\"_blank\">Q2</a>.</li><li>Used vehicle sales expanded 7.6% to $3.97B.</li><li>Total wholesale vehicle unit sales advanced 14.6% to 120,866 and total sales grew 14.6% to $628M.</li><li>CarMax Auto Finance income increased 1.6% to $109.7M.</li><li>Average selling prices: Used vehicles: $20,005 (+1.7%), Wholesale vehicles: $4,955 (flat).</li><li>Gross margin rate fell 10 bps to 13.7%.</li><li>Gross profit per used vehicle flat at $2,179.</li><li>Gross profit per wholesale&nbsp;vehicle up 10.8% to $919.</li><li>During the quarter, the company repurchased 2.3M shares for $171.2M.</li><li>KMX&nbsp;<font color='green'>+1.32%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3393011-carmax-beats-0_02-beats-revenue\" target=\"_blank\">CarMax beats by $0.02, beats on revenue</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393022\" data-linked=\"Car Max beat Q2 estimates\" data-tweet=\"$KMX - Car Max beat Q2 estimates https://seekingalpha.com/news/3393022-car-max-beat-q2-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3393022-car-max-beat-q2-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393017\" data-ts=\"1537962817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393017-gopro-up-5-after-oppenheimer-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro up 5% after Oppenheimer upgrade</a></h4><ul><li>\"GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>) has done <a href=\"https://www.streetinsider.com/Analyst+Comments/Oppenheimer+Upgrades+GoPro+%28GPRO%29+to+Outperform/14643348.html\" target=\"_blank\">everything it can to position</a> itself for success,\" says&nbsp;analyst Andrew Uerkwitz , upgrading to Outperform with $9 price target.</li><li>He's impressed with the new product launch, noting features like live streaming and gimbal-like image stabilization. \"This should be enhanced by targeted marketing and a vastly improved software editing suite.\"</li><li>Shares&nbsp;<font color='green'>+5%</font>&nbsp;premarket to $6.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393017\" data-linked=\"GoPro up 5% after Oppenheimer upgrade\" data-tweet=\"$GPRO - GoPro up 5% after Oppenheimer upgrade https://seekingalpha.com/news/3393017-gopro-up-5-after-oppenheimer-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3393017-gopro-up-5-after-oppenheimer-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393010\" data-ts=\"1537962024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CONE\" target=\"_blank\">CONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393010-cyrusoneminus-4_5-premarket-after-stock-offering-prices-62-per-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CyrusOne -4.5% premarket after stock offering prices at $62 per share</a></h4><ul><li>CyrusOne (NASDAQ:<a href='https://seekingalpha.com/symbol/CONE' title='CyrusOne'>CONE</a>)<font color='red'> drops 4.5%</font>&nbsp;in premarket trading after its offering of 8M shares<a href=\"https://seekingalpha.com/pr/17281369-cyrusone-inc-prices-public-offering-common-stock\" target=\"_blank\"> prices at</a> $62 per share.</li><li>CONE closed trading Tuesday at $64.66. Shares fell to $61.75 in premarket action.</li><li>The company is offering 5.5M directly; 2.5M additional shares are being offered through&nbsp; a forward sale agreement with Morgan Stanley.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392894-cyrusone-starts-8m-share-stock-offering\" target=\"_blank\">CyrusOne starts 8M-share stock offering</a> (Sept. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3393010\" data-linked=\"CyrusOne -4.5% premarket after stock offering prices at $62 per share\" data-tweet=\"$CONE - CyrusOne -4.5% premarket after stock offering prices at $62 per share https://seekingalpha.com/news/3393010-cyrusoneminus-4_5-premarket-after-stock-offering-prices-62-per-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3393010-cyrusoneminus-4_5-premarket-after-stock-offering-prices-62-per-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3393005\" data-ts=\"1537961608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNOV\" target=\"_blank\">MNOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3393005-medicinova-up-2-premarket-on-potential-approval-path-for-mnminus-166-in-als\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MediciNova up 2% premarket on potential approval path for MN-166 in ALS</a></h4><ul><li>Thinly traded MediciNova (NASDAQ:<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17281092-medicinova-announces-positive-fda-feedback-regarding-phase-3-plan-mnminus-166-ibudilast-als\" target=\"_blank\">announcement </a>that, based on FDA feedback, only one Phase 3 study may be required to support a U.S. marketing application for MN-166 (ibudilast) for amyotrophic lateral sclerosis &#40;ALS&#41; if it demonstrates a statistically significant treatment benefit compared to control.</li><li>The FDA also suggests enrolling a broad ALS population with randomization stratified by disease severity.</li><li>No safety issues were cited.</li><li>Considering the rare nature (and well-documented resistance to treatment) of ALS, there may be \"flexibility\" in the requirements to support a marketing application.</li></ul><div class=\"tiny-share-widget\" data-id=\"3393005\" data-linked=\"MediciNova up 2% premarket on potential approval path for MN-166 in ALS\" data-tweet=\"$MNOV - MediciNova up 2% premarket on potential approval path for MN-166 in ALS https://seekingalpha.com/news/3393005-medicinova-up-2-premarket-on-potential-approval-path-for-mnminus-166-in-als?source=tweet\" data-url=\"https://seekingalpha.com/news/3393005-medicinova-up-2-premarket-on-potential-approval-path-for-mnminus-166-in-als\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3392999\" data-ts=\"1537961186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANAB\" target=\"_blank\">ANAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3392999-anaptysbio-prices-public-offering-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AnaptysBio prices public offering of common stock</a></h4><ul> <li>AnaptysBio (NASDAQ:<a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio'>ANAB</a>) <a href=\"https://seekingalpha.com/pr/17281102-anaptysbio-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 2.2M shares of common stock at a price of $94.46 per share, for the gross proceeds of ~$207.8M.</li><li>Underwriters over-allotment is an&nbsp;additional 330,000 shares.</li>   <li>Net proceeds will be used to fund R&amp;D activities for its clinical development programs and for working capital and other general corporate purposes.</li><li>Closing date is September 28.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3392999\" data-linked=\"AnaptysBio prices public offering of common stock\" data-tweet=\"$ANAB - AnaptysBio prices public offering of common stock https://seekingalpha.com/news/3392999-anaptysbio-prices-public-offering-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3392999-anaptysbio-prices-public-offering-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3392998\" data-ts=\"1537960996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3392998-aldeyras-reproxalap-shows-positive-action-in-mid-stage-dry-eye-study-shares-ahead-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aldeyra&#39;s reproxalap shows positive action in mid-stage dry eye study; shares ahead 6% premarket</a></h4><ul><li>Thinly traded micro cap Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17281322-aldeyra-therapeutics-announces-positive-results-phase-2b-dry-eye-disease-clinical-trial\" target=\"_blank\">announcement </a>of positive results from a Phase 2b clinical trial evaluating topical ocular reproxalap in patients with dry eye disease.</li><li>Patients receiving the 0.25% concentration of reproxalap showed statistically significant reductions in Four-Symptom Ocular Dryness Score (p&lt;0.05) and Overall Ocular Discomfort Score (p&lt;0.05). Symptom improvement compared to vehicle (placebo) was observed across all measures.</li><li>A Phase 3 study will launch in 2019.</li><li>Management will host a conference call this morning at 8:00 am ET to discuss the results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3392998\" data-linked=\"Aldeyra&#39;s reproxalap shows positive action in mid-stage dry eye study; shares ahead 6% premarket\" data-tweet=\"$ALDX - Aldeyra&#39;s reproxalap shows positive action in mid-stage dry eye study; shares ahead 6% premarket https://seekingalpha.com/news/3392998-aldeyras-reproxalap-shows-positive-action-in-mid-stage-dry-eye-study-shares-ahead-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3392998-aldeyras-reproxalap-shows-positive-action-in-mid-stage-dry-eye-study-shares-ahead-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}